# FDA Inspection 805513 - Biomat USA, Inc. - October 16, 2012

Source: https://www.globalkeysolutions.net/records/fda_inspections/biomat-usa-inc/faaceb1b-5dd8-4bd1-aad8-67882dee3e88/
Source feed: FDA_Inspections

> FDA Inspection 805513 for Biomat USA, Inc. on October 16, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 805513
- Company Name: Biomat USA, Inc.
- Inspection Date: 2012-10-16
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1167592 - 2022-03-17](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/5722e8d4-b7f2-495b-bd9c-bd1123aa0458/)
- [FDA Inspection 1167592 - 2022-03-17](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/40021918-758a-42dc-9a8f-e7671228f28b/)
- [FDA Inspection 1015150 - 2017-06-07](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/7de4b16f-7465-4ace-979b-5303c9810961/)
- [FDA Inspection 903957 - 2014-11-14](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/08502862-cad2-4d3b-bb22-8b2576fbb931/)
- [FDA Inspection 722053 - 2011-04-27](https://www.globalkeysolutions.net/api/records/fda_inspections/biomat-usa-inc/9b50947d-b6fc-4923-b19a-6820daa2ac93/)

Company: https://www.globalkeysolutions.net/companies/biomat-usa-inc/ccc26b45-b9b6-4395-88ca-26df055c5b63

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d